Efficacy and safety of a fixed bimonthly ranibizumab treatment regimen in eyes with neovascular age-related macular degeneration: results from the RABIMO trial.
| Image |  |
|---|---|
| Description | scientific article published on 19 January 2017 |
| Author/s |
author: Hans Hoerauf Nicolas Feltgen |
| Publication date | January 19, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |